跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,098 条关于
“Dragon Overseas Capital Limited”
全部
15,098
临床试验
2,190
药物
84
机构
1,475
资讯
11,349
11个月前
Sapu Nano's Injectable Everolimus Formulation Sapu003 Receives Approval for Phase 1 Breast Cancer Trial
上个月
Dragon Boat Paddling Offers Physical and Psychosocial Healing for Cancer Survivors
去年
Belite Bio's Tinlarebant Phase III DRAGON Trial Approaches Critical Milestone for Stargardt Disease Treatment
2个月前
GW RhythmX Launches RhythmX Pulse on Microsoft Marketplace, Integrating Precision Care AI with Dragon Copilot
去年
DSMB Endorses Continuation of Phase 3 DRAGON Trial for Tinlarebant in Stargardt Disease
22天前
CanSinoBIO Reports 43.8% Revenue Growth as Overseas Business and mRNA Pipeline Expand
2年前
Belite Bio Doses First Patient in Phase 2/3 DRAGON II Trial of Tinlarebant for Stargardt Disease
上个月
SINOVAC Posts 12.9% Revenue Growth on Overseas Expansion, Advances Late-Stage Vaccine Pipeline
9个月前
Belite Bio Raises $350 Million to Advance Retinal Disease Therapies Toward Commercialization
9个月前
FDA Proposes Higher User Fees for Overseas Phase I Trials to Boost Domestic Drug Development
第 1 页，共 1135 页
上一页
下一页
